On September 5, 2023, Academician Cheng Jinpei, a famous organic chemist and professor of Tsinghua University and Nankai University, Professor Zhang Wanbin of Shanghai Jiao Tong University, Profess...

Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administr...

July 15, 2023，Sirnaomics and Aurisco jointly explore opportunities and pathways to overcome challenges in the development and manufacturing of oligonucleotides, aiming to strengthening cooperation ...

Aurisco Pharmaceutical’s Oral Dydrogesterone Tablets Get Marketing Authorization Approval in China Under The Brand Name AUXITON®. See attachment for details: Auri...

Refer to the attachment for more details. Aurisco 25th year anniversary

January 3,2023，Aurisco to build an Oligonucleotide FlexFactory™ for commercial cGMP production in cooperation with Cytiva. In future, Aurisco’s new commercial manufacturing site in Yangzhou, ...

On July7, 2021, Shanghai Aurisco Biotechnology Co., Ltd., with aninvestment of RMB 60 million by Aurisco Pharmaceutical Co.,Ltd., was formally esta...

On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB8.37, number of shares issued is...